Informing the public about advances in cancer therapy

European Journal of Cancer Care

Volumn 11, Issue 1, 2002, Pages 25-32

  Geraghty, James G ^a   Zbar, A ^a   Costa, A ^a  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

Author keywords

Cancer; New research; Public education; Therapeutic advances

Indexed keywords

ARTICLE; HEALTH EDUCATION; HUMAN; INTERPERSONAL COMMUNICATION; MEDICAL PROFESSION; NEOPLASM; RESEARCH;

COMMUNICATION; HEALTH EDUCATION; HEALTH OCCUPATIONS; HUMANS; NEOPLASMS; RESEARCH;

EID: 1842835834     PISSN: 09615423     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2354.2002.00285.x     Document Type: Article

References (54)

1. Anderson L.M. & May D.S. (1995) Has the use of cervical, breast and colorectal cancer screening increased in the United States? American Journal of Public Health 85 (6), 840-842.
2. Antman K., Bearman S., Davidson N. et al. (1990) High dose treatment in breast cancer with autologous bone marrow support: current status. In: New Strategies in Bone Marrow Transplantation (eds Gale R.P. & Champlin R.E.). AR Liss Inc, New York.
3. Boldrini G., de Gaetano A.M., Giovanni I. et al. (1987) The systematic use of operative ultrasonography for detection of liver metastases during colorectal cancer surgery. World Journal of Surgery 11, 622-627.
4. Bonadonna G., Valagussa P., Tancini G. et al. (1986) Current status of the Milan adjuvant chemotherapy trials for node positive and node negative breast cancer. National Cancer Institute Monograph 1, 45-49.
5. Buhle E.L., Goldwein J.W. & Benjamin I. (1994) ONCOLINK: a multimedia oncology information resource on the internet. Proceedings of the symposium on computer applications in medicine. Journal of the American Medical Information Association (Symposium Suppl.), 103-107.
6. Chiesa F., Tradati N., Marazza M. et al. (1992) Prevention of local relapses and new localisation of oral leukolakias with synthetic retinoid fenretinide (4-HPR). Oral Oncological European Journal of Cancer 28B, 97-102.
7. Coiera E. (1995) Medical informatics. British Medical Journal 310, 1381-1387.
8. Costa A. (1993) Breast cancer chemoprevention. European Journal of Cancer 29A (4), 589-592.
9. Daniels N. (1986) Why saying 'no' to patients in the United States is so hard: cost containment, justice and provider autonomy. New England Journal of Medicine 314, 1380-1383.
10. Doll F.R.S. & Peto R. (1981) The causes of cancer. Oxford University Press, New York.
11. Early Breast Cancer Triallists Collaborative Group (1992) Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy: 133 randomised trials. Lancet 3339 (1-15), 71-85.
12. Einhorn L.H. (1981) Testicular Cancer - a model for a curable neoplasm. Cancer Research 41, 3275-3280.
13. Elders M.J., Perry C.L. & Enderson M.P. (1994) The report of the Surgeon General; preventing tobacco use among young people. American Journal of Public Health 84 (4), 543-547.
14. Fearon E.R. & Vogelstein B. (1990) A genetic model for colorectal tumourigenesis. Cell 61, 759-767.
15. Fitzgerald F.T. (1994) The tyranny of health. New England Journal of Medicine 331, 196-198.
16. Garniek D.W., Hendricks A.M. & Brennan T.A. (1991) Can practice guidelines reduce the number and costs of malpractice claims? Journal of the American Medical Association 266, 2856-2860.
17. Geraghty J.G. & Young H.L. (1996) Satellite delivered continuing medical education in Europe. Postgraduate Medicine Journal 72, 218-220.
18. Groden J., Thlivaris A., Samowitz W. et al. (1991) Identification and characterisation of the familial adenomatous polyposis coli gene. Cell 66, 589-600.
19. Hakama M., Miller A.B. & Day N.E. (eds.) (1986) IARC Working Group on Screening of the Uterine Cervix. IARC Scientific Publications, Lyon, France, No. 76.
20. Hawkins R.E. (1994) Engineering antibodies for targeted cancer therapy. In: New Approaches In Cancer Pharmacology (ed. Workman P.), pp. 87-89. Drug Design and Development, Vol 2, Springer-Verlag, Berlin.
21. Hawkins R.E. (1994) Engineering antibodies for targeted cancer therapy. In: New Approaches In Cancer Pharmacology (ed. Workman P.), pp. 87-89. Drug Design and Development, Vol 2, Springer-Verlag, Berlin.
22. Henderson I.C., Hayes D.F. & Gelman R. (1988) Dose response in the treatment of breast cancer: a critical review. Journal of Clinical Oncology 6, 1501-1505.
23. Hertz R., Lewis J.L. & Lipsett M.B. (1986) Five year's experience with the chemotherapy of metastatic choriocarcinoma and related trophoblastic disease. Gynaecology Oncology 23, 111.
24. Hortobagyi G.N. (1992) Overview of new therapies for breast cancer. Breast Cancer Research and Treatment 21, 3-13.
25. Hurowitz J.C. (1993) Towards a special policy for health. New England Journal of Medicine 329 (2), 130-133.
26. JNCI News (1994) Interactive technology enters the realm of cancer education. Journal of the National Cancer Institute 86 (17), 1272-1273.
27. Jubelirer S.J., Linton J.C. & Magnetti S.M. (1994) Reading versus comprehension - implications for patient education and consent in an outpatient oncology department. Journal of Cancer Education 9, 26-29.
28. Kwak L.W., Campbell M.J. & Czerwinski D.K. (1992) Introduction of immune responses in patients with B cell lymphoma against the surface immunoglobulin idiotype expressed by these tumours. New England Journal of Medicine 327, 1209-1225.
29. Lukens J.N. (1994) Progressing results from clinical trials. Solid tumours in childhood cancer. Cancer 74, 2710-2718.
30. Mick R., Begg C.B., Antman K. et al. (1989) Diverse prognosis in metastatic breast cancer: who should be offered alternative initial treatments. Breast Cancer Research and Treatment 13, 33-38.
31. Miki Y., Swensen J., Shattuck-Eidens D. et al. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA 1. Science 266, 66-71.
32. Miller R.W., Young J.L. & Novakovic B. (1994) Chidhood cancer. Cancer 75, 395-405.
33. Mitchell J.B. & Glatstein E. (1991) Radiation oncology: past achievements and ongoing controversies. Cancer Research Supplement 51, 5056-5073.
34. Morris A., East C., Wallace C. et al. (1994) Ethical implications of standardisation of ICU care with computerised protocols: Proceedings of the Symposium on computer applications in medicine. Journal of the American Information Association (Symposium Suppl.), 501-505.
35. Morstyn G. & Kaye A.H. (1990) Photodynamic Therapy for Cancer. Harwood Academic Publisher, Switzerland.
36. Penhamberger H., Binder M. & Knollmayer S. (1993) Immediate effects of a public education campaign on prognostic features of melanoma. Journal of the American Academy of Dermatology 29, 106-109.
37. Pierquin B.L. (1983) Past, present and future of interstitial radiation therapy. International Journal of Radiation Oncology, Biology, Physics 9, 1237-1242.
38. Plainfosse M.C. & Bouillot J.L. (1987) The use of operative sonographyin carcinoma of the pancreas. World Journal of Surgery 11, 654-658.
39. Platt J.F., Rubin J.M., Chandler W.F. et al. (1988) Intraoperative spinal ultrasonography in the evaluation of intramedullary tumours. Journal of Ultrasound Medicine 7, 317-325.
40. Preston J., Brown P.W. & Hartley B. (1991) Using Telemedicine to improve healthcare in distant areas. Hospital Communications Psychology 43, 25-31.
41. Roman S.D., Clarke C.L., Hull R.E. et al. (1992) Expression and regulation of retinoic acid receptors in human breast cancer cells. Cancer Research 52, 2236-2242.
42. Rosenberg S.A., Aebersold P., Cornetta K. et al. (1990) Gene transfer into humans: Immunotherapy of patients with advanced melanoma using tumour infiltrating lymphocytes modified by retrieval gene transduction. New England Journal of Medicine 323 (8), 570-578.
43. Rosenman J., Sherouse G.W., Fuchs H. et al. (1989) Three dimensional display techniques in radiation therapy treatment planning. International Journal of Radiation Oncology, Biology, Physics 16, 263-269.
44. Russo A., Mitchell J.B., Kinsella T. et al. (1985) Determinants of Radiosensitivity. Seminars in Oncology 12, 332-349.
45. Schain W.S. (1994) Barriers to clinical trials. Part 2. Knowledge and attitudes of potential participants. Cancer 74, 2666-2671.
46. Shapiros Venet W., Strax P. et al. (1982) Ten to fourteen year effect of screening on breast cancer mortality. Journal of National Cancer Institute 69, 349-355.
47. Sporn M.B. & Newton D.L. 9 (1979) Chemoprevention of carcinoma and retinoids. Fed Proceedings of The 38, 2528-2534.
48. Tabar L., Fagerberg G., Duffy S.V. et al. (1989) The Swedish two country trial of mammographic screening for breast cancer; recent results and calculation of benefit. Journal of Epidemiology Community Health 43, 107-114.
49. Tate T., Brace J.A., Morgan H. et al. (1986) Conformational treatment - a method of improving the tumour treatment Volume ratio. Clinical Radiology 37, 267-271.
50. Tobias J.S. & Souhami R.L. (1993) Fully informed consent can be needlessly cruel. British Medical Journal 307, 1199-1201.
51. Veronesi U., Saccozi R., Del-Vecchio M. et al. (1981) Comparing radical mastectomy with quadrantectomy, axillary dissection and radiotherapy in patients with small cancers of the breast. New England Journal of Medicine 305, 6-11.
52. Wardle J. & Pope R. (1992) The psychological costs of screening for cancer. Journal of Psychometric Research 36, 609-624.
53. Wooster R., Bignell G., Lancaster J. et al. (1995) Identification of the breast cancer gene BRCA2. Nature 378, 789-791.
54. Young J.L., Ries L.G., Silverberg E. et al. (1986) Cancer incidence, survival and mortality for children younger than age 15 years. Cancer 58, 598-602.